The main reason for using next-generation sequencing is the effective reduction in turnaround time with NGS compared to traditional methods. At the same time, next-generation sequencing makes it possible to analyze the transcriptome and genome of a species in a detailed and holistic way. CD Genomics offers a growing range of services, from library construction to sequencing to complete experimental design and support. Our Illumina NextSeq 2000-based next-generation sequencing technology can help you advance genome engineering innovation.
Specifications
1. Three output sizes available: P1, P2, and P3 producing 100 million, 400 million, or 1 billion reads (or read pairs) per run respectively.
2. P1 is available only as a 300 cycle kit.
3. P2 and P3 are available as 100, 200 or 300 cycle kits.
4. One library pool per flow cell, no individual lane loading.
5. Sample multiplexing available from 96-384 samples, depending on the application.
MANUFACTURER: Illumina
The Illumina NextSeq 2000 is our newest short-read sequencer, and has replaced the NextSeq 550.
The sequencing chemistry is similar across all Illumina platforms. Libraries compatible with one Illumina sequencer should be compatible with all Illumina sequencers.
1. Used for a variety of applications, including but not limited to:
2. De novo whole genome sequencing
3. Whole genome resequencing
4. Exome sequencing
5. RNA-Seq
6. scRNA-Seq
7. miRNA/small RNA-Seq
8. ChIP-Seq
9. RIP-Seq
10. Degradome sequencing
CD Genomics, as a specialist sequencing company, has a large range of sequencers in our NGS Core, including Illumina MiSeq, NovaSeq, PacBio, and more. If you require this service, please contact us directly.
For research use only, not intended for any clinical use.
Online Inquiry
Please fill out the form below and we will get back to you as soon as possible with a quotation for the item you are interested in.